Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1.

Nag, Nupur

Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1. [electronic resource] - Cerebellum (London, England) Feb 2013 - 74-82 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1473-4230

10.1007/s12311-012-0399-x doi


Amantadine--pharmacology
Animals
Ataxin-1
Ataxins
Buspirone--pharmacology
Disease Models, Animal
Dopamine Agents--pharmacology
Genotype
Hypnotics and Sedatives--pharmacology
Kyphosis--genetics
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Motor Activity--drug effects
Nerve Tissue Proteins--genetics
Neuroprotective Agents--pharmacology
Nuclear Proteins--genetics
Phenotype
Purkinje Cells--drug effects
Pyridines--pharmacology
Riluzole--pharmacology
Serotonin Receptor Agonists--pharmacology
Spinocerebellar Ataxias--drug therapy
Zolpidem